Ready Brand Medicines for Brazil: How to Manage Product Changes After Supplier Approval

Ready Brand Medicines for Brazil: How to Manage Product Changes After Supplier Approval

• Medical
• November 02, 2026

What Is a Product Change After Supplier Approval?

A product change is a difference from the product details or supply arrangements previously reviewed and accepted.

For this article, “ready brand medicines” refers to finished medicines offered under an existing brand. The term does not establish the medicine’s regulatory classification or authorisation in Brazil.

Product Changes May Include:

• Manufacturing site changes.
• Formulation changes.
• Material specification changes.
• Manufacturing process changes.
• Quality-control method changes.
• Primary packaging changes.
• Carton artwork revisions.
• Pack configuration changes.
• Shelf-life changes.
• Storage and transport condition changes.

Some changes concern commercial arrangements, while others may affect product quality or registered conditions. Each proposal needs an assessment appropriate to its nature.

Why Do Product Changes Need Careful Management?

Supplier approval is based on the information available during qualification.

It does not automatically cover every product version, manufacturing location or packaging arrangement introduced later.

A Product Change Review May Need to Address:

• What has changed from the accepted product.
• Why the change is proposed.
• Which products and presentations are affected.
• Whether quality documentation needs updating.
• Whether Brazilian registered conditions are affected.
• Which batches contain the change.
• Whether open orders require revision.
• How existing stock will be handled.
• Who must approve the proposed implementation.
• What evidence is needed before dispatch.

The objective is to maintain a clear connection between the product accepted by the buyer and the product supplied.

Define the Approved Product and Supply Details

Prepare a controlled record of the product information accepted during supplier qualification and product review.

This record provides the baseline against which future changes can be compared.

The Initial Record Should Include:

• Product name and brand.
• Strength and dosage form.
• Manufacturer.
• Manufacturing site.
• Pack configuration.
• Product specification reference.
• Packaging material details.
• Artwork version.
• Shelf life.
• Storage conditions.
• Transport requirements.
• Required quality documents.
• Relevant regulatory references.
• Approved commercial requirements.
• Responsible review contacts.

Keep internal supplier approval records distinguishable from regulatory authorisations.

Update the baseline only after the relevant change assessment and approval activities have been completed.

Confirm the Difference Between Supplier Approval and Regulatory Approval

Supplier qualification, product acceptance and regulatory authorisation serve different purposes.

A buyer may approve a supplier commercially while additional product-specific requirements remain outstanding.

Anvisa explains that post-registration changes are classified according to their potential impact on quality, safety and efficacy. Depending on the applicable requirements, changes may qualify for immediate implementation under specified conditions or require prior approval.

Details to Confirm:

• Product regulatory status in Brazil.
• Identity of the Brazilian registration holder.
• Applicable medicine category.
• Registered conditions potentially affected.
• Required regulatory assessment.
• Supporting documentation.
• Applicable submission requirements.
• Conditions governing implementation.

The responsible Brazilian regulatory team should document the product-specific pathway.

Do not assume that a supplier’s internal approval establishes permission to implement the change for Brazil.

Review the Quality Agreement and Notification Responsibilities

Check whether the quality agreement or other controlled arrangement explains how proposed changes must be communicated.

The notification process should reach the people responsible for quality and regulatory assessment, rather than only the purchasing contact.

Agreement Details to Review:

• Changes requiring notification.
• Notification sender and recipients.
• Required notice period.
• Information accompanying the notification.
• Acknowledgement process.
• Technical review responsibilities.
• Regulatory review responsibilities.
• Approval authority.
• Treatment of affected orders.
• Dispatch conditions.
• Escalation arrangements.
• Record-retention responsibilities.

Agree notification timing that allows the necessary assessment.

A commercial delivery target should not replace outstanding quality or regulatory requirements.

Request a Complete Product Change Description

Establish exactly what is changing before deciding whether the proposal can be accepted.

A general statement such as “new packaging introduced” may conceal several differences requiring separate consideration.

Review Steps May Include:

1. Identify the Product: Confirm the brand, strength, dosage form and presentation.
2. Record the Change Reference: Use a unique supplier or manufacturer reference.
3. Describe the Current Arrangement: Identify the accepted condition and document version.
4. Describe the Proposed Arrangement: Explain the intended difference clearly.
5. Confirm the Reason: Record why the change is being proposed.
6. Identify Supporting Evidence: List the available technical documents.
7. Establish the Proposed Timing: Identify implementation dates and affected batches where available.
8. Record Outstanding Questions: Assign owners to obtain missing information.

For example:

Current arrangement: Ten saleable packs per shipping carton.

Proposed arrangement: Twenty saleable packs per shipping carton.

This identifies a configuration change. The review should also establish whether artwork, shipping dimensions or protective packaging changes accompany it.

Assess Quality and Technical Implications

Identify how the proposal could affect the product, its controls or its suitability for the intended supply arrangement.

The assessment should reflect the actual change rather than a fixed document request applied to every situation.

Possible Assessment Areas Include:

• Product specifications.
• Material suitability.
• Manufacturing controls.
• Analytical methods.
• Stability information.
• Packaging protection.
• Container-closure performance, where relevant.
• Storage conditions.
• Transport requirements.
• Supporting qualification or validation work.

Comparison Points Include:

• Differences from the accepted baseline.
• Evidence supporting the proposed arrangement.
• Limitations in the available information.
• Additional testing or documentation needed.
• Product presentations affected.
• Conditions required before acceptance.

Keep the technical conclusions linked to the evidence reviewed.

An unchanged brand name or strength does not, by itself, establish that a proposed change has no quality implications.

Obtain a Product-Specific Regulatory Assessment

Provide the complete change description to the responsible Brazilian regulatory team.

The assessment should consider the medicine’s category and the conditions relevant to its authorisation.

Regulatory Information to Request:

• Product and registration references.
• Description of affected registered conditions.
• Applicable change classification.
• Required supporting documents.
• Submission or notification requirements.
• Prior approval requirements, where applicable.
• Implementation conditions.
• Relevant regulatory evidence.
• Responsibilities for follow-up.
• Restrictions affecting supply.

Record the conclusion in writing.

Avoid using one product’s regulatory assessment as the automatic basis for a different medicine or a different type of change.

Review Packaging, Artwork and Product Information

Some proposals involve changes to both packaging materials and printed information.

Review these elements separately so a visual comparison does not overlook a technical difference.

Packaging Review May Include:

• Primary packaging materials.
• Closure components.
• Secondary packaging.
• Protective inserts.
• Saleable pack configuration.
• Shipping carton configuration.
• Packaging dimensions.
• Relevant transport protection.

Artwork Details to Review:

• Product and brand name.
• Strength and dosage form.
• Pack quantity.
• Manufacturer information.
• Relevant Brazilian company information.
• Storage statements.
• Batch and expiry marking areas.
• Product identifiers.
• Leaflet references.
• Document version numbers.

Use controlled artwork files and clearly identify superseded versions.

The responsible team should confirm the suitability of the proposed information for the intended market.

Confirm Affected Batches and Open Orders

Connect the proposed change with identifiable batches and purchase orders.

A planned implementation date may not be sufficient when production schedules change or both versions remain in stock.

Information to Review:

• Last batch under the previous arrangement.
• First batch under the changed arrangement.
• Manufacturing dates.
• Available stock by version.
• Open purchase orders.
• Orders awaiting production.
• Orders awaiting dispatch.
• Shipments already in transit.
• Customer commitments.
• Relevant expiry dates.

Keep batch information current as implementation progresses.

Where the first affected batch is not yet known, record who will confirm it before allocation or dispatch.

Plan the Transition Between Product Versions

Determine how previous-version stock and changed stock will be handled.

Do not assume that existing stock must be discarded or that changed stock can immediately replace it.

Transition Review Questions Include:

• Can existing stock continue to be supplied?
• Which markets can receive each version?
• Is segregation required?
• Do open orders need written revision?
• Are customers expecting a particular presentation?
• Are receiving instructions current?
• What happens to obsolete packaging materials?
• Who authorises stock disposition?
• What evidence is required before dispatch?
• How will the transition be recorded?

Any proposed relabelling or repacking should receive its own assessment before work begins.

Document the agreed transition instructions and communicate them to the relevant teams.

Add Quality, Regulatory and Commercial Decisions to the Change Record

A change record should show which reviews have been completed and what remains outstanding.

Commercial acceptance should not be used as a substitute for a quality or regulatory decision.

Decision Records May Include:

• Change reference.
• Products affected.
• Documents reviewed.
• Quality assessment outcome.
• Regulatory assessment outcome.
• Commercial implications.
• Outstanding conditions.
• Approval or rejection status.
• Applicable batches.
• Implementation date or boundary.
• Authorised reviewers.
• Communication records.

Where approval is conditional, make the conditions specific and assign responsibility for completion.

An internal decision should not be described as Anvisa approval without supporting regulatory evidence.

Assign Change Responsibilities Across the Supply Chain

A product change may require information from several organisations.

Assign an owner to coordinate the review and maintain the consolidated record.

Functions to Involve May Include:

• Manufacturer’s quality assurance team.
• Manufacturer’s regulatory team.
• Supplier or exporter.
• Buyer’s procurement team.
• Brazilian registration holder.
• Brazilian importer.
• Receiving warehouse.
• Logistics provider.
• Commercial team.
• Customer service team.

Confirm who provides each document, who assesses it and who authorises the next step.

The exporter, importer and registration holder may have different responsibilities within the arrangement.

A Practical Product Change Management Checklist

Hypothetical Example: Managing a Packaging Change After Approval

A buyer has approved a supplier for a branded medicine intended for Brazil.

Before a repeat order, the supplier proposes revised carton artwork and an increased number of saleable packs per shipping carton.

The following example illustrates the review process. It does not establish the regulatory classification of an actual change.

Illustrative Review Breakdown:

• Product identity: The affected brand, strength and presentation are confirmed.
• Change description: Current and proposed artwork files are provided.
• Packaging scope: The manufacturer confirms whether primary packaging also changes.
• Quality assessment: The relevant team reviews the available supporting information.
• Regulatory assessment: The Brazilian registration holder determines the applicable requirements.
• Commercial review: Procurement checks ordering units and quotation details.
• Logistics review: Revised carton dimensions and handling arrangements are assessed.
• Batch transition: The first affected batch is identified.
• Decision: Implementation conditions are recorded.
• Receiving preparation: The warehouse receives current approved instructions.

The changed product is allocated to an order only when the relevant acceptance and implementation conditions have been satisfied.

Keeping these decisions together helps prevent conflicting instructions between procurement, dispatch and receiving teams.

Separate Approval Status From Implementation Status

A change may be approved for implementation while required actions remain incomplete.

Maintain a clear distinction between the decision and evidence that the decision has been carried out correctly.

Separate Status Views May Include:

• Notification received.
• Information requested.
• Quality review in progress.
• Regulatory review in progress.
• Decision pending.
• Approved with conditions.
• Ready for implementation.
• Implemented.
• Verification complete.
• Closed or rejected.

Define what each status means within the business’s procedure.

Do not close a change solely because an approval email has been issued.

Verify Implementation and Reconcile Product Records

Check the first affected shipment against the authorised change record.

Confirm that the goods, documents and internal systems reflect the same product version.

Records to Reconcile Include:

• Approved change record.
• Current specifications.
• Approved artwork.
• Purchase order.
• Commercial invoice.
• Packing list.
• Batch documentation.
• Required quality certificates.
• Warehouse receiving records.
• Product master data.

Receiving Checks May Include:

• Product name and presentation.
• Batch number.
• Pack quantity.
• Artwork version.
• Printed batch and expiry information.
• Shipping carton configuration.
• Required documentation.
• Relevant storage instructions.

Record unexpected differences and refer them to the responsible quality team.

Where an unnotified change is discovered, control the affected stock while the difference and its implications are assessed.

Common Mistakes to Avoid

Treating Supplier Approval as Permanent Product Acceptance

Assess proposed differences against the accepted product baseline.

Accepting a Supplier’s Change Classification Without Review

Obtain the underlying details and complete the appropriate quality and regulatory assessments.

Checking Artwork Without Reviewing Packaging Materials

Confirm whether the proposal includes technical changes beyond its appearance.

Using Dates Without Identifying Batches

Connect implementation with traceable batches and affected orders.

Allowing Delivery Pressure to Replace Required Assessment

Plan supply around the documented approval and implementation conditions.

Leaving Warehouses With Superseded Information

Provide current approved instructions before changed goods arrive.

Confusing Internal Acceptance With Regulatory Authorisation

Keep the evidence and responsibilities for each decision clear.

Closing Changes Without Verification

Confirm that required actions and product records have been updated.

Working With Zircon Medtech on Product Changes

When discussing ready brand medicines for Brazil with Zircon Medtech, provide a clear description of the accepted product and your notification expectations.

Request a process that identifies proposed differences, supporting documents and the parties responsible for assessment.

Information to Share Includes:

• Product name, strength and dosage form.
• Accepted pack configuration.
• Manufacturer and manufacturing site.
• Current specification references.
• Current artwork versions.
• Required quality documents.
• Relevant Brazilian regulatory contacts.
• Open purchase orders.
• Expected dispatch periods.
• Change-notification requirements.
• Approval responsibilities.
• Batch-transition expectations.

Confirm which information Zircon Medtech will coordinate and which evidence must come from the manufacturer, importer or registration holder.

Keeping Product Changes Controlled After Supplier Approval

Ready brand medicines for Brazil benefit from a consistent process for managing differences after supplier qualification.

Define the accepted baseline, obtain complete change information and connect quality and regulatory reviews with affected batches and orders.

A documented process helps the parties maintain clear product records, communicate implementation conditions and verify the goods supplied after a change.